Esperion Therapeutics, Inc. (NASDAQ: ESPR) Stock Information | RedChip

Esperion Therapeutics, Inc. (NASDAQ: ESPR)


$2.2900
-0.0100 ( +2.23% ) 2.0M

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Market Data


Open


$2.2900

Previous close


$2.3000

Volume


2.0M

Market cap


$453.18M

Day range


$2.1870 - $2.3050

52 week range


$1.5800 - $3.9400

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 May 28, 2024
4 Insider transactions 2 May 24, 2024
4 Insider transactions 2 May 24, 2024
4 Insider transactions 2 May 24, 2024
4 Insider transactions 2 May 24, 2024
4 Insider transactions 2 May 24, 2024
4 Insider transactions 2 May 24, 2024
4 Insider transactions 2 May 24, 2024
4 Insider transactions 2 May 24, 2024
4 Insider transactions 2 May 20, 2024

Latest News